{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:59:25Z","timestamp":1781333965901,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1038\/s41390-020-01140-8","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T12:02:59Z","timestamp":1599912179000},"page":"871-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic\u2013ischemic encephalopathy undergoing therapeutic hypothermia"],"prefix":"10.1038","volume":"88","author":[{"given":"Adam","family":"Frymoyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisa P.","family":"Van Meurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Drover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie Y.","family":"Chock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpeds.2012.10.002","volume":"162","author":"DT Selewski","year":"2013","unstructured":"Selewski, D. T., Jordan, B. K., Askenazi, D. J., Dechert, R. E. & Sarkar, S. Acute kidney injury in asphyxiated newborns treated with therapeutic hypothermia. J. Pediatr. 162, 725\u2013729.e1 (2013).","journal-title":"J. Pediatr."},{"key":"1140_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00467-018-4068-2","volume":"34","author":"MJ Kirkley","year":"2019","unstructured":"Kirkley, M. J. et al. Acute kidney injury in neonatal encephalopathy: an evaluation of the AWAKEN database. Pediatr. Nephrol. 34, 169\u2013176 (2019).","journal-title":"Pediatr. Nephrol."},{"key":"1140_CR3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-016-3317-5","volume":"31","author":"C Gupta","year":"2016","unstructured":"Gupta, C., Massaro, A. N. & Ray, P. E. A new approach to define acute kidney injury in term newborns with hypoxic ischemic encephalopathy. Pediatr. Nephrol. 31, 1167\u20131178 (2016).","journal-title":"Pediatr. Nephrol."},{"key":"1140_CR4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ki.1988.114","volume":"33","author":"JB Gouyon","year":"1988","unstructured":"Gouyon, J. B. & Guignard, J. P. Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int. 33, 1078\u20131083 (1988).","journal-title":"Kidney Int."},{"issue":"Suppl. 1","key":"1140_CR5","first-page":"S33","volume":"43","author":"H Osswald","year":"1995","unstructured":"Osswald, H., Gleiter, C. & M\u00fchlbauer, B. Therapeutic use of theophylline to antagonize renal effects of adenosine. Clin. Nephrol. 43(Suppl. 1), S33\u2013S37 (1995).","journal-title":"Clin. Nephrol."},{"key":"1140_CR6","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1542\/peds.105.4.e45","volume":"105","author":"AG Jenik","year":"2000","unstructured":"Jenik, A. G. et al. A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia. Pediatrics 105, E45 (2000).","journal-title":"Pediatrics"},{"key":"1140_CR7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00467-005-1980-z","volume":"20","author":"AF Bakr","year":"2005","unstructured":"Bakr, A. F. Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia\u2014a study in a developing country. Pediatr. Nephrol. 20, 1249\u20131252 (2005).","journal-title":"Pediatr. Nephrol."},{"key":"1140_CR8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpeds.2006.03.053","volume":"149","author":"MA Bhat","year":"2006","unstructured":"Bhat, M. A., Shah, Z. A., Makhdoomi, M. S. & Mufti, M. H. Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J. Pediatr. 149, 180\u2013184 (2006).","journal-title":"J. Pediatr."},{"key":"1140_CR9","first-page":"222","volume":"3","author":"Z Eslami","year":"2009","unstructured":"Eslami, Z., Shajari, A., Kheirandish, M. & Heidary, A. Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia. Iran. J. Kidney Dis. 3, 222\u2013226 (2009).","journal-title":"Iran. J. Kidney Dis."},{"key":"1140_CR10","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1111\/apa.13469","volume":"105","author":"A Raina","year":"2016","unstructured":"Raina, A., Pandita, A., Harish, R., Yachha, M. & Jamwal, A. Treating perinatal asphyxia with theophylline at birth helps to reduce the severity of renal dysfunction in term neonates. Acta Paediatr. 105, e448\u2013e451 (2016).","journal-title":"Acta Paediatr."},{"key":"1140_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.34172\/aim.2020.20","volume":"23","author":"M Saboute","year":"2020","unstructured":"Saboute, M. et al. Effect of aminophylline in preventing renal dysfunction among neonates with prenatal asphyxia: a clinical trial. Arch. Iran. Med. 23, 312\u2013318 (2020).","journal-title":"Arch. Iran. Med."},{"key":"1140_CR12","doi-asserted-by":"crossref","unstructured":"Chock, V. Y., Cho, S.-H. & Frymoyer, A. Aminophylline for renal protection in neonatal hypoxic\u2013ischemic encephalopathy in the era of therapeutic hypothermia. Pediatr. Res. (2020). [Online ahead of print].","DOI":"10.1038\/s41390-020-0999-y"},{"key":"1140_CR13","unstructured":"Hospira, Inc. FDA package insert aminophylline (aminophylline injection, solution) (2009)."},{"key":"1140_CR14","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archpedi.155.8.934","volume":"155","author":"JA Lowry","year":"2001","unstructured":"Lowry, J. A., Jarrett, R. V., Wasserman, G., Pettett, G. & Kauffman, R. E. Theophylline toxicokinetics in premature newborns. Arch. Pediatr. Adolesc. Med. 155, 934\u2013939 (2001).","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"1140_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jp.2010.146","volume":"31","author":"S Zanelli","year":"2011","unstructured":"Zanelli, S., Buck, M. & Fairchild, K. Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J. Perinatol. 31, 377\u2013386 (2011).","journal-title":"J. Perinatol."},{"key":"1140_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fped.2020.00239","volume":"8","author":"M O\u2019Dea","year":"2020","unstructured":"O\u2019Dea, M. et al. Management of multi organ dysfunction in neonatal encephalopathy. Front. Pediatr. 8, 239 (2020).","journal-title":"Front. Pediatr."},{"key":"1140_CR17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/phar.1263","volume":"33","author":"A Frymoyer","year":"2013","unstructured":"Frymoyer, A., Meng, L., Bonifacio, S. L., Verotta, D. & Guglielmo, B. J. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy 33, 718\u2013726 (2013).","journal-title":"Pharmacotherapy"},{"key":"1140_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jcph.775","volume":"57","author":"A Frymoyer","year":"2017","unstructured":"Frymoyer, A. et al. Decreased morphine clearance in neonates with hypoxic ischemic encephalopathy receiving hypothermia. J. Clin. Pharm. 57, 64\u201376 (2017).","journal-title":"J. Clin. Pharm."},{"key":"1140_CR19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0033-1358749","volume":"225","author":"L Welzing","year":"2013","unstructured":"Welzing, L. et al. Disposition of midazolam in asphyxiated neonates receiving therapeutic hypothermia\u2014a pilot study. Klin. Padiatr. 225, 398\u2013404 (2013).","journal-title":"Klin. Padiatr."},{"key":"1140_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000457157","volume":"7","author":"P Gal","year":"1984","unstructured":"Gal, P., Toback, J., Erkan, N. V. & Boer, H. R. The influence of asphyxia on phenobarbital dosing requirements in neonates. Dev. Pharm. Ther. 7, 145\u2013152 (1984).","journal-title":"Dev. Pharm. Ther."},{"key":"1140_CR21","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMcps050929","volume":"353","author":"S Shankaran","year":"2005","unstructured":"Shankaran, S. et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 353, 1574\u20131584 (2005).","journal-title":"N. Engl. J. Med."},{"key":"1140_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/pr.2017.15","volume":"81","author":"A Frymoyer","year":"2017","unstructured":"Frymoyer, A., Juul, S. E., Massaro, A. N., Bammler, T. K. & Wu, Y. W. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Pediatr. Res. 81, 865\u2013872 (2017).","journal-title":"Pediatr. Res."},{"key":"1140_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson, B. J. & Holford, N. H. G. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharm. Toxicol. 48, 303\u2013332 (2008).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"1140_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S2352-4642(17)30069-X","volume":"1","author":"JG Jetton","year":"2017","unstructured":"Jetton, J. G. et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc. Health 1, 184\u2013194 (2017).","journal-title":"Lancet Child Adolesc. Health"},{"key":"1140_CR25","first-page":"279","volume":"49","author":"PH Hinderling","year":"1997","unstructured":"Hinderling, P. H. Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharm. Rev. 49, 279\u2013295 (1997).","journal-title":"Pharm. Rev."},{"key":"1140_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2007-994095","volume":"14","author":"R Mazkereth","year":"1997","unstructured":"Mazkereth, R. et al. Effects of theophylline on renal function in premature infants. Am. J. Perinatol. 14, 45\u201349 (1997).","journal-title":"Am. J. Perinatol."},{"key":"1140_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fped.2014.00059","volume":"2","author":"RF Tamburro","year":"2014","unstructured":"Tamburro, R. F. et al. A prospective assessment of the effect of aminophylline therapy on urine output and inflammation in critically ill children. Front. Pediatr. 2, 59 (2014).","journal-title":"Front. Pediatr."},{"key":"1140_CR28","first-page":"80","volume":"13","author":"BA Lynch","year":"2008","unstructured":"Lynch, B. A. et al. Low-dose aminophylline for the treatment of neonatal non-oliguric renal failure-case series and review of the literature. J. Pediatr. Pharm. Ther. 13, 80\u201387 (2008).","journal-title":"J. Pediatr. Pharm. Ther."},{"key":"1140_CR29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.ajkd.2012.02.332","volume":"60","author":"B Dai","year":"2012","unstructured":"Dai, B. et al. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am. J. Kidney Dis. 60, 360\u2013370 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"1140_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pcc.0000436473.12082.2f","volume":"15","author":"DM Axelrod","year":"2014","unstructured":"Axelrod, D. M. et al. Initial experience using aminophylline to improve renal dysfunction in the pediatric cardiovascular ICU. Pediatr. Crit. Care Med. 15, 21\u201327 (2014).","journal-title":"Pediatr. Crit. Care Med."},{"key":"1140_CR31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s001340050723","volume":"24","author":"M Bell","year":"1998","unstructured":"Bell, M., Jackson, E., Mi, Z., McCombs, J. & Carcillo, J. Low-dose theophylline increases urine output in diuretic-dependent critically ill children. Intens. Care Med. 24, 1099\u20131105 (1998).","journal-title":"Intens. Care Med."},{"key":"1140_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10928-009-9143-7","volume":"37","author":"K Brendel","year":"2010","unstructured":"Brendel, K., Comets, E., Laffont, C. & Mentr\u00e9, F. Evaluation of different tests based on observations for external model evaluation of population analyses. J. Pharmacokinet. Pharmacodyn. 37, 49\u201365 (2010).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"1140_CR33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets, E., Brendel, K. & Mentr\u00e9, F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput. Methods Prog. Biomed. 90, 154\u2013166 (2008).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"1140_CR34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40262-012-0004-y","volume":"51","author":"MPH van den Broek","year":"2012","unstructured":"van den Broek, M. P. H. et al. Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach. Clin. Pharmacokinet. 51, 671\u2013679 (2012).","journal-title":"Clin. Pharmacokinet."},{"key":"1140_CR35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00007691-198603000-00002","volume":"8","author":"JT Gilman","year":"1986","unstructured":"Gilman, J. T., Gal, P., Levine, R. S., Hersh, C. B. & Erkan, N. V. Factors influencing theophylline disposition in 179 newborns. Ther. Drug Monit. 8, 4\u201310 (1986).","journal-title":"Ther. Drug Monit."},{"key":"1140_CR36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00007611-198207000-00017","volume":"75","author":"P Gal","year":"1982","unstructured":"Gal, P., Boer, H. R., Toback, J., Wells, T. J. & Erkan, N. V. Effect of asphyxia on theophylline clearance in newborns. South Med. J. 75, 836\u2013838 (1982).","journal-title":"South Med. J."},{"key":"1140_CR37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01059087","volume":"17","author":"ES Moore","year":"1989","unstructured":"Moore, E. S., Faix, R. G., Banagale, R. C. & Grasela, T. H. The population pharmacokinetics of theophylline in neonates and young infants. J. Pharmacokinet. Biopharm. 17, 47\u201366 (1989).","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"1140_CR38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197608192950803","volume":"295","author":"JV Aranda","year":"1976","unstructured":"Aranda, J. V., Sitar, D. S., Parsons, W. D., Loughnan, P. M. & Neims, A. H. Pharmacokinetic aspects of theophylline in premature newborns. N. Engl. J. Med. 295, 413\u2013416 (1976).","journal-title":"N. Engl. J. Med."},{"key":"1140_CR39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00007691-199912000-00003","volume":"21","author":"MJ du Preez","year":"1999","unstructured":"du Preez, M. J., Botha, J. H., McFadyen, M. L. & Holford, N. H. The pharmacokinetics of theophylline in premature neonates during the first few days after birth. Ther. Drug Monit. 21, 598\u2013603 (1999).","journal-title":"Ther. Drug Monit."},{"key":"1140_CR40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","volume":"14","author":"BB Fredholm","year":"2007","unstructured":"Fredholm, B. B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315\u20131323 (2007).","journal-title":"Cell Death Differ."},{"key":"1140_CR41","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/jpet.105.091017","volume":"315","author":"PB Hansen","year":"2005","unstructured":"Hansen, P. B. et al. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J. Pharm. Exp. Ther. 315, 1150\u20131157 (2005).","journal-title":"J. Pharm. Exp. Ther."},{"key":"1140_CR42","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/jm0104318","volume":"45","author":"S-A Kim","year":"2002","unstructured":"Kim, S.-A. et al. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J. Med. Chem. 45, 2131\u20132138 (2002).","journal-title":"J. Med. Chem."},{"key":"1140_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00005131","volume":"357","author":"KN Klotz","year":"1998","unstructured":"Klotz, K. N. et al. Comparative pharmacology of human adenosine receptor subtypes\u2014characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharm. 357, 1\u20139 (1998).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"1140_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2299(199905)47:1<45::AID-DDR6>3.0.CO;2-U","volume":"47","author":"KA Jacobson","year":"1999","unstructured":"Jacobson, K. A., Ijzerman, A. P. & Linden, J. 1,3-Dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptors. Drug Dev. Res. 47, 45\u201353 (1999).","journal-title":"Drug Dev. Res."},{"key":"1140_CR45","doi-asserted-by":"crossref","first-page":"e0211910","DOI":"10.1371\/journal.pone.0211910","volume":"14","author":"LMA Favi\u00e9","year":"2019","unstructured":"Favi\u00e9, L. M. A. et al. Pharmacokinetics of morphine in encephalopathic neonates treated with therapeutic hypothermia. PLoS ONE 14, e0211910 (2019).","journal-title":"PLoS ONE"},{"key":"1140_CR46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/bcp.12883","volume":"81","author":"YA Bijleveld","year":"2016","unstructured":"Bijleveld, Y. A. et al. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia. Br. J. Clin. Pharm. 81, 1067\u20131077 (2016).","journal-title":"Br. J. Clin. Pharm."},{"key":"1140_CR47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00216-011-4775-z","volume":"400","author":"CF Clavijo","year":"2011","unstructured":"Clavijo, C. F. et al. A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 400, 715\u2013728 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"1140_CR48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fped.2019.00535","volume":"7","author":"RK Basu","year":"2019","unstructured":"Basu, R. K. Dynamic biomarker assessment: a diagnostic paradigm to match the AKI syndrome. Front. Pediatr. 7, 535 (2019).","journal-title":"Front. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01140-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01140-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T23:11:23Z","timestamp":1631401883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01140-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-01140-8","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.F. is a scientific consultant for Takeda Pharmaceuticals unrelated to this work. D.R.D. is a scientific consultant for Masimo Corporation and AbbVie Inc. unrelated to this work. The other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained for patients in the prospective study. A waiver of consent was granted for the retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of consent"}}]}}